Ocumetics Technology is trading at CA$0.46 (+13.58%), with completion of its final private-placement tranche providing the clearest company-specific catalyst for the advance.

  • On August 24, 2026, Ocumetics Technology announced completion of its third and final private-placement tranche, issuing 405,000 units at $0.40 for $162,000.
  • The financing raised $3.11 million overall and will support first-in-human trials, Group Two surgeries, research, working capital, and FDA IDE preparations targeted for early 2027.
  • The announcement does not explicitly attribute the price movement to the financing; trading volume was not provided.